Home Tools
Log in
Cart

Search Result

Search Results for " egf "

20

Compounds

Cat No. Product Name Synonyms Targets
TP1807 EGF Receptor Substrate 2 Phospho-Tyr5
EGF Receptor Substrate 2 (Phospho-Tyr5) is a biologically active peptide derived from an autophosphorylation site (Tyr992) of EGFR.
T3506 Nazartinib EGF816,NVS-816 EGFR
Nazartinib (EGF816) (EGF816, NVS-816) is a covalent, irreversible, mutant-selective EGFR inhibitor that has nanomolar inhibitory potency against activating mt (L858R, ex19del) and T790M mt, with up to 60-fold selectivity...
T75764 EGF Receptor Substrate 2 (Phospho-Tyr5)
EGF Receptor Substrate 2 (Phospho-Tyr5) is a biologically active peptide derived from an autophosphorylation site (Tyr 992 ) of epidermal growth factor receptor (EGFR).
T76472 EGF-R (661-681) T669 Peptide
EGF-R (661-681) T669 Peptide, a MAPK substrate, facilitates the measurement of MAPK catalytic activity [1].
T14004 1A-116 Rho
1A-116 is a specific inhibitor of Rac1 .
T8574 SPHINX Others
SPHINX is a new generation inhibitor of SPRK1
T11156L Nazartinib mesylate EGF816 (mesylate) Others
Nazartinib mesylate is a novel, covalent mutant-selective inhibitor of EGFR (Ki and Kinact: 31 nM and 0.222/min on EGFR(L858R/790M) mutant).
T9927 Panitumumab EGFR
Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).
T11156 Nazartinib S-enantiomer EGF816 (S-enantiomer) Others
Nazartinib is an EGFR inhibitor. Nazartinib S-enantiomer is the less active S-enantiomer of Nazartinib.
T75120 EGFR-IN-76 EGFR
EGFR-IN-76 is a potent EGFR inhibitor.
T37078 VEGFR-2-IN-6 VEGFR
VEGFR-2-IN-6 (WO 02/059110, example 64) is a potent inhibitor of VEGFR2, a crucial receptor involved in the regulation of angiogenesis [1].
T63732 EGFR-IN-3 Apoptosis , EGFR
EGFR-IN-3 is an EGFR inhibitor with potential antitumour activity.EGFR-IN-3 inhibits EGFRwt-TK and induces apoptosis (cell death), which can cause cells to block in the G2/M phase.
T10802 CHMFL-EGFR-202 EGFR
CHMFL-EGFR-202 is a potent, irreversible inhibitor of EGFR mutant kinase (IC50s: 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases).
T72924 VEGFR-3-IN-1 VEGFR
VEGFR-3-IN-1 is a novel potent and selective VEGFR3 inhibitor with an IC50 of 110.4 nM.VEGFR-3-IN-1 possesses antitumor activity, inactivates the VEGFR3 signaling pathway, and inhibits the proliferation and migration of ...
T11161 EGFR-IN-7 TQB3804 EGFR
EGFR-IN-7 (TQB3804) is a selective and potent EGFR kinase inhibitor.
T11160 EGFR-IN-5 EGFR
EGFR-IN-5 is a selective inhibitor of EGFR. The IC50s for EGFR, EGFR(L858R), EGFR(L858R/T790M), and EGFR(L858R/T790M/C797S) are 10.4, 1.1, 34, 7.2 nM, respectively.
T9979 VEGFR-2-IN-29 VEGFR
VEGFR-2-IN-29 is a VEGFR2 inhibitor.
T16162 Mutated EGFR-IN-1 Osimertinib analog EGFR
Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.
T10123 VEGFR-2-IN-9 KDR-in-4 VEGFR
VEGFR-2-IN-9 (KDR-in-4) is a potent KDR/VEGFR2 inhibitor (IC50: 7 nM). It can be used to study breast cancer.
T11157L EGFR-IN-1 hydrochloride EGFR
EGFR-IN-1 hydrochloride is an irreversible and specific inhibitor of L858R/T790M mutant EGFR with 100-fold selectivity over wild-type EGFR. EGFR-IN-1 hydrochloride exhibits potent antitumor and antiproliferative activity...
1 2 3 4 5 6 7 8 9 10 11 12 13
TargetMol